Showing results (41-50 of 217) with videos related to
Sort By:
Pageof 22
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|January 4, 2019
Association between UGT1A1 gene polymorphism and safety and efficacy of irinotecan monotherapy as the third-line treatment for advanced gastric cancerToshifumi Yamaguchi, Satoru Iwasa, Hirokazu Shoji, et al.International Journal of Clinical Oncology|November 19, 2004
Phase I/II study of irinotecan, 5-fluorouracil, and l-leucovorin combination therapy (modified Saltz regimen) in patients with metastatic colorectal cancerAyumu Goto, Yasuhide Yamada, Ayumu Hosokawa, et al.Hepato-Gastroenterology|September 15, 2004
Long-term survivor of gastric small cell carcinomaAyumu Hosokawa, Yasuhiro Shimada, Kuniaki Shirao, et al.International Journal of Clinical Oncology|October 18, 2011
Phase II clinical trial of second-line FOLFIRI plus bevacizumab for patients with metastatic colorectal cancer: AVASIRI trialYosuke Horita, Yasuhide Yamada, Ken Kato, et al.Anticancer Research|May 7, 2013
KRAS mutations in patients with colorectal cancer as detected by high-resolution melting analysis and direct sequencingKohei Akiyoshi, Yasuhide Yamada, Yoshitaka Honma, et al.Journal of Cancer Research and Clinical Oncology|October 17, 2013
Impact of adding cisplatin to S-1 in elderly patients with advanced gastric cancerTetsuji Terazawa, Satoru Iwasa, Atsuo Takashima, et al.Japanese Journal of Clinical Oncology|April 7, 2011
A Phase I/II trial of chemoradiotherapy concurrent with S-1 plus mitomycin C in patients with clinical Stage II/III squamous cell carcinoma of anal canal (JCOG0903: SMART-AC)Atsuo Takashima, Yasuhiro Shimada, Tetsuya Hamaguchi, et al.International Journal of Clinical Oncology|December 10, 2003
Phase I study of irinotecan and S-1 combination therapy in patients with metastatic gastric cancerYasuhide Yamada, Hisateru Yasui, Ayumu Goto, et al.International Journal of Clinical Oncology|November 19, 2004
Prognostic significance of thymidylate synthase in patients with metastatic colorectal cancer who receive protracted venous infusions of 5-fluorouracilAyumu Hosokawa, Yasuhide Yamada, Yasuhiro Shimada, et al.Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|December 24, 2004
Retrospective analysis of clinical results and predictors of response in chemo-naive patients with advanced gastric cancer treated with S-1, an oral fluoropyrimidine derivative, as single-agent chemotherapyKan Yonemori, Yasuhiro Shimada, Ayumu Goto, et al.Pageof 22